TN MPJE Practice Questions and Answers Graded A+

TN MPJE Practice Questions and Answers Graded A+ To assist the Board of Pharmacy in enforcing pharmaceutical laws, the board must employ investigators who: Are pharmacists Pharmacy Tech, takes a call from a physician who is calling in a new prescription for a patient. Pharmacy Tech may receive the new prescription as long as he is: Certified Pharmacist has been asked by the Tennessee Board of Pharmacy's peer review committee to provide information regarding the competency of PharmD. Pharmacist provides factual information that he believes to be true. As a result of their investigation, the Board revokes PharmD's license. PharmD sues Pharmacist for defamation. As part of the defamation lawsuit, PharmD requests a copy of the information given by Pharmacist to the Board. PharmD is: Not entitled to receive the information because it is privileged. Testimony given to board is privileged. Privileged = disclosure of information cannot be compelled, even by a court of law. This info is not a public record and is not available under court subpoena for discovery proceedings. Nurse practitioners and physician assistants are prohibited from: Writing a rx order for any medication if the sole purpose is to cause an abortion Pharmacist receives an electronic order from an individual practitioner for a Schedule III drug. Pharmacy cannot fill the order because it is out of stock of the drug ordered. Pharmacist should: Decline to fill order at this time because the drug is not in stock A pharmacist realizes that the pharmacy's stock of Schedule II drugs is too high. The pharmacist decides to return half of the Schedule II drugs in stock to the manufacturer. To return the excess stock: Manufacturer send Pharmacist the appropriate order form keeping copy 3; Pharmacist keeps copy 1 and sends copy 2 to DEA Scheduled listed chemical products include products that: According to 21 USCS § 802 (45) (A), the term scheduled listed chemical product means, "subject to subparagraph (B), a product that-- (i) contains ephedrine, pseudoephedrine, or phenylpropanolamine; and (ii) may be marketed or distributed lawfully in the United States under the Federal, Food, Drug, and Cosmetic Act as a nonprescription drug. Each reference in clause (i) to ephedrine, pseudoephedrine, or phenylpropanolamine includes each of the salts, optical isomers, and salts of optical isomers of such chemical. (B) Such term does not include a product described in subparagraph (A) if the product contains a chemical specified in such subparagraph that the Attorney General has under section 201(a) [21 USCS § 811(a)] added to any of the schedules under section 202(c) [21 USCS § 812(c)]. In the absence of such scheduling by the Attorney General, a chemical specified in such subparagraph may not be considered to be a controlled substance." The Administrator of the DEA added the drug PainBeGone to Schedule III effective October 24, 2016. PainBeGone had not been listed in any schedule prior to that date. Pharmacy's most recent inventory was December 31, 2014. Pharmacy: Must inventory its stock of PainBeGone on October 24, 2016 A pharmacist realizes that the pharmacy's stock of controlled substances is dwindling faster than prescription orders justify. After laying a clever trap, the pharmacist catches a pharmacy tech in the act of stealing from bulk containers of controlled substances. Under the federal Controlled Substance Act, the pharmacist must report the theft to the DEA on form: 106 within one business day of discovering the theft 106 - loss/theft 107 - loss of a listed chemical Registration for a DEA number is based upon the: Independent activity or activities engaged in by the registrant